Medical Compression Systems, Inc. (MCS) has just announced upcoming launch of ActiveCare Online, its platform meant to improve clinical outcomes following total hip or knee replacement. Because ActiveCare Online is equipped with Bluetooth, patients and healthcare providers can wirelessly transmit important data; they can also communicate with patients using text messages.
Medical Compression Systems Launches ActiveCare Online

“By adding new monitoring and communications capabilities to our ActiveCare platform, we expect to simultaneously improve patient outcomes and reduce hospital costs, ” said Timothy A. McCarthy, CEO of MCS, in the March 1, 2016 news release. “We predict our system’s close post-surgical surveillance will decrease hospital readmissions, and we are committed to providing daily treatment guidance through the ActiveCare Online and the new ActiveCare Customer Care Center. In addition to outcome improvements and cost reductions, we also anticipate better institutional quality metrics following the adoption of our technology.”
“An established body of scientific evidence has confirmed that prophylactic treatment with mobile compression combined with aspirin chemoprophylaxis following total joint replacement can reduce the occurrence of venous thromboembolism and decrease adverse events, infections and bleeding complications in standard risk patients, ” said Richard Iorio, M.D., an orthopedic surgeon in New York. “The next generation ActiveCare System improves on existing technology by improving connectivity between the patient, hospital and physician, which has the potential to improve clinical outcomes and reduce costs to the healthcare system.”
Timothy McCarthy told OTW, “During the AAOS [American Academy of Orthopaedic Surgeons] conference in March, we received strong initial interest in ActiveCare Online, our next-generation platform for improving clinical outcomes following total hip or knee replacements, and are looking forward to making it available in the U.S. We’re confident that the unique combination of a proven mobile compression device treatment for DVT [deep vein thrombosis] prevention and communication capabilities, enabling wireless data transmission between patients and healthcare providers, will appeal to hospitals closely monitoring post discharged patient (patients at home) and by that reducing readmissions. We expect broad adoption of our new system when it becomes available.”
As indicated in the news release, “MCS has filed for 501(k) clearance from the U.S. Food and Drug Administration and expects to launch ActiveCare Online in the second half of 2016.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.